Abstract
Children and adolescents infected with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) are usually asymptomatic or have mild coronavirus disease (COVID-19) with low rates of hospitalization and death. Multisystem inflammatory syndrome in children (MIS-C) is a rare and severe complication of SARS-CoV-2 infection. This paper reviews an excerpt of the literature on disease burden and complications following COVID-19 in children and adolescents aged 0-17 years, in addition to the effects and adverse drug reactions of BNT162b2 and mRNA-1273 vaccinations among children and adolescents aged 5-17 years.
Translated title of the contribution | COVID-19 among children and adolescents |
---|---|
Original language | Danish |
Article number | V11210858 |
Journal | Ugeskrift for Laeger |
Volume | 184 |
Issue number | 9 |
Number of pages | 6 |
ISSN | 0041-5782 |
Publication status | Published - 2022 |